ETFsBloomberg MSCI ESG Euro Corp BBB+ 0-3 Year Select Index
Amundi

Amundi EUR Corporate Bond 0-3Y ESG UCITS ETF Acc

ECR3 XETRAAccumulatingPhysical, full replicationLuxembourgNot PEA-eligible
Last close · EUR
54.55EUR
-0.02% · -€0.01
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
ECR3Base
Fund charges
0.12%Total expense ratio (TER)
Fund size
€3.7bnall share classes
Return 1Y
+1.3%
Sharpe 3Y
0.46
Volatility 1Y
1.0%annualised
Holdings
1,379Fund holdings

Performance

Compare
  • ECR3+1.3%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
ECR3+0.3%+0.2%+0.9%+1.1%+1.3%+10.3%+8.6%
MSCI World-2.8%-0.6%+7.8%+14.0%+14.1%+65.6%+64.8%
Gap to MSCI World+3.2%+0.8%-6.9%-12.9%-12.8%-55.3%-56.2%

Risk and return

Sharpe ratio · 3Y
0.46
Below MSCI World · 1.24
Return p.a.
+3.3%
Volatility
1.0%
Max loss
-0.9%Mar 2026

Sharpe vs indices

MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
ECR3
0.46
CAC 40
0.37
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
2.1%
Holdings
1,379
As of
Fund holdings
  1. 1JPMORGAN CHAS VAR Mar30 EMTNXS24612346220.24%
  2. 2MORGAN STANLE VAR Mar29XS25950285360.21%
  3. 3CRED AGRICOLE 2.625% Mar27XS12041544100.21%
  4. 4BANCO SANTAND VAR Apr29XS29087355040.21%
  5. 5GOLDMAN SACHS VAR Jul30 EMTNXS34476512020.20%
  6. 6JPMORGAN CHAS 1.638% May28 EMTNXS16150799740.20%
  7. 7MORGAN STANLE 1.875% Apr27 EMTNXS16038921490.20%
  8. 8AXA SA VAR May49 EMTNXS17996116420.20%
  9. 9WELLS FARGO C 1% Feb27 EMTNXS14630439730.19%
  10. 10GOLDMAN SACHS VAR Feb29 EMTNXS32994721110.19%

Countries

Not published · Country classification unavailable

Market cap

Weight vs holdings

2.1%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.